NYSE:IH iHuman (IH) Stock Price, News & Analysis $1.03 -0.04 (-3.36%) Closing price 03:39 PM EasternExtended Trading$1.00 -0.03 (-2.80%) As of 04:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsNews and TrendsSEC Filings About iHuman Stock (NYSE:IH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get iHuman alerts:Sign Up Key Stats Today's Range$1.00▼$1.0150-Day Range$1.02▼$1.2552-Week Range$1.00▼$2.99Volume1,097 shsAverage Volume2,793 shsMarket Capitalization$52.86 millionP/E Ratio17.83Dividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview iHuman Inc. (NYSE: IH) is a children’s education technology company that develops digital learning products and educational content. The company focuses on helping young learners build foundational skills through interactive, multimedia-based lessons and activities. Its product portfolio includes mobile applications and related educational offerings covering subjects such as Chinese language, English, mathematics, reading and general early-childhood learning. iHuman’s products are designed to combine animated content, games, songs and other interactive features to support learning both at home and in other educational settings. Founded in China, iHuman primarily serves children and families in the Chinese market while also offering selected products to users in international markets. The company distributes its offerings through digital platforms and has also developed associated physical educational products and services.AI Generated. May Contain Errors. Read More iHuman Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks17th Percentile Overall ScoreIH MarketRank™: 0.848884248985 of 5 starsiHuman scored higher than 17% of companies evaluated by MarketBeat, and ranked 200th out of 230 stocks in the communication services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingiHuman has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageiHuman has only been the subject of 1 research reports in the past 90 days.Read more about iHuman's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of iHuman is 17.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.47.Price to Earnings Ratio vs. SectorThe P/E ratio of iHuman is 17.24, which means that it is trading at a less expensive P/E ratio than the Communication Services sector average P/E ratio of about 26.32.Price to Book Value per Share RatioiHuman has a P/B Ratio of 0.37. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about iHuman's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.00% of the float of iHuman has been sold short.Short Interest Ratio / Days to CoveriHuman has a short interest ratio ("days to cover") of 0.35, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous month Dividend0.0 / 5Dividend StrengthN/A Dividend YieldiHuman does not currently pay a dividend.Dividend GrowthiHuman does not have a long track record of dividend growth. News and Social MediaN/ANews SentimentN/A Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, iHuman insiders have not sold or bought any company stock.Percentage Held by Insiders63.60% of the stock of iHuman is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions4.92% of the stock of iHuman is held by institutions.Read more about iHuman's insider trading history. Receive IH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iHuman and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IH Stock News HeadlinesIHuman Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026September 29, 2026 | marketscreener.comMIHuman Q2 Slips Into Loss From Higher ExpensesSeptember 29, 2026 | rttnews.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 12 at 1:00 AM | Profits Run (Ad)iHuman Inc. Announces Second Quarter 2026 Unaudited Financial ResultsSeptember 29, 2026 | prnewswire.comiHuman Inc. ADRAugust 12, 2026 | marketwatch.comiHuman Inc. Announces First Quarter 2026 Unaudited Financial ResultsJune 29, 2026 | prnewswire.comJazz Pharmaceuticals Delivers Extensive Late-Breaking Data at SLEEP 2026, Demonstrating Real-World Impact of Xywav® (calcium, magnesium, potassium, and sodium oxybates) on Patient Outcomes Across Narcolepsy and Idiopathic HypersomniaJune 16, 2026 | prnewswire.comiHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect LingoMay 31, 2026 | prnewswire.comSee More Headlines IH Stock Analysis - Frequently Asked Questions How have IH shares performed this year? iHuman's stock was trading at $2.1050 at the beginning of the year. Since then, IH shares have decreased by 50.9% and is now trading at $1.0340. How were iHuman's earnings last quarter? iHuman Inc. Sponsored ADR (NYSE:IH) released its quarterly earnings results on Tuesday, September, 29th. The company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by $0.07. The business earned $25.52 million during the quarter, compared to analyst estimates of $33.94 million. iHuman had a net margin of 3.06% and a trailing twelve-month return on equity of 2.44%. When did iHuman IPO? iHuman (IH) raised $84 million in an initial public offering on Friday, October 9th 2020. The company issued 7,000,000 shares at $11.00-$13.00 per share. Credit Suisse and Citigroup served as the underwriters for the IPO and Tiger Brokers, CMBI and CLSA were co-managers. How do I buy shares of iHuman? Shares of IH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings9/29/2026Today11/12/2026Next Earnings (Estimated)12/17/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (8m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 IH's financial health is in the Red zone, according to TradeSmith. IH has been in this zone for over 8 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorCommunication Services Industry Entertainment Sub-IndustryInteractive Home Entertainment Current SymbolNYSE:IH CIK1814423 Webwww.ihuman.com Phone86-10-5780-6636FaxN/AEmployees558Year Founded2016Profitability EPS (Trailing Twelve Months)$0.06 Trailing P/E Ratio17.24 Forward P/E RatioN/A P/E GrowthN/ANet Income$13.64 million Net Margins3.06% Pretax Margin3.48% Return on Equity2.44% Return on Assets1.73% Debt Debt-to-Equity RatioN/A Current Ratio2.91 Quick Ratio2.83 Sales & Book Value Annual Sales$115.40 million Price / Sales0.46 Cash Flow$0.29 per share Price / Cash Flow3.53 Book Value$2.78 per share Price / Book0.37Miscellaneous Outstanding Shares51,120,000Free Float18,607,000Market Cap$52.86 million OptionableNot Optionable Beta-0.01 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:IH) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredManagement just bought 2.8 million sharesManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | SponsoredElon wants to move AI off the planet. Amazon isn't ready.What if the next AI race isn't on Earth? Tim Bohen's Mission X presentation explores Elon Musk's idea of movin...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iHuman Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share iHuman With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
